CHOP is markedly elevated in the intestinal epithelium of IBD patients and murine models, where it exacerbates colitis by inhibiting peroxisome proliferator-activated receptor γ (PPARγ), a negative regulator of NF-κB. This evidence concerns the gene DDIT3 and inflammatory bowel disease.